| Literature DB >> 28930211 |
Abstract
Plants produce a wide diversity of secondary meEntities:
Keywords: bioactivity; evolutionary pharmacology; non-specific interaction; phytotherapy; plant secondary metabolite; specific interactions
Year: 2015 PMID: 28930211 PMCID: PMC5456217 DOI: 10.3390/medicines2030251
Source DB: PubMed Journal: Medicines (Basel) ISSN: 2305-6320
Use and bioactivity of a few selective secondary metabolites which are applied as isolated compounds in medicine [12]; alkaloid (A), terpenoids (T) [11,12,13,14].
| Plant Species | Substance (Class) | Mode of Action | Properties/Applications |
|---|---|---|---|
| aconitine (A) | activates Na+ channels | analgesic | |
| antagonist of mAChR | parasympathomimetic | ||
| camptothecin (A) | inhibitor of DNA topoisomerase | tumour therapy | |
| tetrahydrocannabinol (T) | activates THC receptor | analgesic | |
| dimeric Vinca alkaloids (A) | inhibit microtubule assembly | tumor therapy | |
| tubocurarine (A) | inhibits nAChR | muscle relaxant | |
| quinidine (A) | inhibits Na+ channels | antiarrhythmic | |
| caffeine (A) | inhibits phosphodiesterase and adenosine receptors | stimulant | |
| colchicine (A) | inhibits microtubule assembly | gout treatment | |
| sparteine (A) | inhibits Na+ channels | antiarrhythmic | |
| digitoxin, digoxin (T) | inhibits Na+,K+-ATPase | heart insufficiency | |
| cocaine (A) | inhibits Na+ channels and reuptake of noradrenaline and dopamine | analgesic; stimulant | |
| galanthamine (A) | inhibits AChE | Alzheimer treatment | |
| huperzine A (A) | inhibits AChE | Alzheimer treatment | |
| morphine (A) | agonist of endorphine receptors | analgesic, hallucinogen | |
| physostigmine (A) | inhibits AChE | Alzheimer treatment | |
| pilocarpine (A) | agonist of mAChR | glaucoma treatment | |
| emetine (A) | protein biosynthesis inhibitor | treatment of amebae infections; emetic | |
| reserpine (A) | inhibits the uptake of noradrenalin into postsynaptic vesicles | hypertonia treatment | |
| sanguinarine (A) | DNA intercalator | antibacterial, antiviral | |
| ouabain (T) | inhibits Na+, K+-ATPase | heart insufficiency | |
| paclitaxel (taxol) (A) | inhibits microtubule disassembly | tumour therapy |
Composition of extracts from medicinal plants used in traditional phytotherapy and their putative interactions [10,11,12].
| Medicinal Plant/Drug | Phenolics * | Terpenoids * | Saponins * | Polysaccharides * | Covalent Interactions ** |
|---|---|---|---|---|---|
| ++ | ++ | ||||
| ++ | ++ | ||||
| + | ++ | ||||
| + | ++ | ||||
| + | ++ | ||||
| ++ | ++ | ||||
| ++ | ++ | + | + | + | |
| ++ | ++ | + | |||
| ++ | ++ | ++ | + | ||
| + | ++ | ||||
| ++ | + | ||||
| ++ | + | ||||
| ++ | ++ | + | |||
| ++ | ++ | + | |||
| ++ | ++ | ||||
| ++ | ++ | ++ | + | ||
| + | ++ | ||||
| ++ | + | ||||
| ++ | ++ | + | |||
| ++ | ++ | ||||
| ++ | ++ | ||||
| ++ | ++ | ++ | |||
| ++ | ++ | ||||
| ++ | ++ | + | + | ||
| + | ++ | ||||
| ++ | ++ | + | |||
| + | + | ++ | |||
| ++ | ++ | ||||
| ++ | ++ | + | ++ | + | |
| ++ | ++ | ||||
| ++ | + | ||||
| ++ | + | ++ | |||
| ++ | ++ | + | |||
| ++ | |||||
| ++ | |||||
| ++ | + | ||||
| ++ | |||||
| ++ | + | ++ | + | ||
| ++ | ++ | ++ | |||
| ++ |
+: present; ++: main compounds; ** for covalent interactions see Figure 1; * for non-covalent interactions of phenolics, terpenoids and saponins see Figure 2 and Figure 3.
Figure 1Secondary metabolites (SM) which form covalent bonds with proteins inducing a conformational change (indicated by the change of the form of the theoretical protein) and thus modulating their bioactivities (after [51,63]). (A) Interactions of SM with SH-groups of proteins and peptides; (B) Interactions of SM with amino groups of proteins or peptides.
Figure 2SM which form hydrogen and ionic bonds with proteins and thus modulate their conformation. (A) Schematic view of possible hydrogen and ionic bond formation by phenolic compounds (here thymol); (B) Examples for widely distributed polyphenols in medicinal plants. Phenolic OH groups are circled (after [51,63]).
Figure 3Interaction of SM with biomembranes. Saponins can complex membrane cholesterol; polyphenols influence 3D structure of membrane proteins (receptors, transporters, ion channels); small lipophilic terpenoids assemble in the inner lipophilic core of the biomembrane (after [11,12])
Estimated number of described secondary metabolites and their main functions for the plants producing them * (after [11,12])
| Class | Numbers of Structures | Toxic or Repellent for Herbivores | Antimicrobial Activity | Attraction of Pollinators or Fruit Dispersers |
|---|---|---|---|---|
| Alkaloids | 27,000 | ++++ | ++ | − |
| Non-protein amino acids (NPAA) | 700 | ++++ | +++ | − |
| Cyanogenic Glucosides/HCN | 60 | ++++ | + | − |
| Mustard oils (Glucosinolates) | 150 | ++++ | ++++ | +/− |
| Amines | 100 | +++ | + | +++ |
| Lectins, Peptides, AMPs | 2000 | +++ | +++ | − |
| Monoterpenes (including Iridoid glucosides) | 3000 | ++ | +++ | +++ |
| Sesquiterpenes | 5000 | +++ | +++ | ++ |
| Diterpenes | 2500 | +++ | +++ | − |
| Triterpenes, Steroids, Saponins (including cardiac glycosides) | 5000 | +++ | +++ | − |
| Tetraterpenes | 500 | + | + | +++ |
| Phenylpropanoids, coumarins, lignans | 2000 | +++ | +++ | ++ |
| Flavonoids, anthocyanins, tannins | 4000 | +++ | +++ | ++ |
| Polyketides (Anthraquinones) | 800 | ++++ | +++ | − |
| Polyacetylenes | 1500 | ++++ | ++++ | − |
| Carbohydrates, organic acids | 600 | + | ++ | + |
* Activity: −: no SM active; +/−: very few SM active; +: few SM active; ++: many SM active; +++: most SM active; ++++: all SM active.